SARTORELLO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 3.254
AS - Asia 1.418
EU - Europa 729
SA - Sud America 251
AF - Africa 244
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 19
Totale 5.946
Nazione #
US - Stati Uniti d'America 3.080
SG - Singapore 463
CN - Cina 255
VN - Vietnam 239
BR - Brasile 157
HK - Hong Kong 132
IT - Italia 126
FI - Finlandia 69
CA - Canada 62
GB - Regno Unito 60
DE - Germania 57
FR - Francia 57
BD - Bangladesh 56
SE - Svezia 50
IN - India 34
PL - Polonia 34
TR - Turchia 26
NL - Olanda 24
RU - Federazione Russa 23
UA - Ucraina 21
EC - Ecuador 20
IQ - Iraq 19
PK - Pakistan 19
AR - Argentina 17
MX - Messico 17
ZA - Sudafrica 17
CI - Costa d'Avorio 16
ES - Italia 16
PH - Filippine 14
BE - Belgio 13
IE - Irlanda 13
CO - Colombia 12
JM - Giamaica 12
LA - Repubblica Popolare Democratica del Laos 12
BJ - Benin 11
EG - Egitto 11
JP - Giappone 11
AT - Austria 10
BF - Burkina Faso 10
BY - Bielorussia 10
CL - Cile 10
PT - Portogallo 10
YT - Mayotte 10
AZ - Azerbaigian 9
DZ - Algeria 9
EE - Estonia 9
HR - Croazia 9
ME - Montenegro 9
PE - Perù 9
AD - Andorra 8
AE - Emirati Arabi Uniti 8
AO - Angola 8
IL - Israele 8
IS - Islanda 8
MA - Marocco 8
MG - Madagascar 8
MN - Mongolia 8
NO - Norvegia 8
PF - Polinesia Francese 8
RE - Reunion 8
VE - Venezuela 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
ID - Indonesia 7
LV - Lettonia 7
RS - Serbia 7
SA - Arabia Saudita 7
SK - Slovacchia (Repubblica Slovacca) 7
TN - Tunisia 7
UG - Uganda 7
AL - Albania 6
CW - ???statistics.table.value.countryCode.CW??? 6
CY - Cipro 6
DJ - Gibuti 6
ET - Etiopia 6
GN - Guinea 6
HN - Honduras 6
IR - Iran 6
KE - Kenya 6
KG - Kirghizistan 6
KR - Corea 6
LC - Santa Lucia 6
LU - Lussemburgo 6
PR - Porto Rico 6
PY - Paraguay 6
RO - Romania 6
TT - Trinidad e Tobago 6
ZW - Zimbabwe 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
BZ - Belize 5
CH - Svizzera 5
CV - Capo Verde 5
DK - Danimarca 5
DM - Dominica 5
GH - Ghana 5
GM - Gambi 5
GR - Grecia 5
HT - Haiti 5
HU - Ungheria 5
Totale 5.716
Città #
Ashburn 512
San Jose 414
Fairfield 308
Singapore 273
Chandler 154
Houston 133
Hong Kong 118
Cambridge 115
Woodbridge 114
Seattle 105
Ann Arbor 84
Wilmington 79
Ho Chi Minh City 68
Santa Clara 62
Council Bluffs 61
Los Angeles 61
Jacksonville 58
Dong Ket 50
Beijing 44
Hanoi 44
Princeton 40
New York 36
Boardman 35
Helsinki 31
Lauterbourg 27
Buffalo 25
San Diego 25
Washington 25
Dallas 23
São Paulo 19
Munich 18
Bytom 17
Nanjing 17
Abidjan 16
Medford 16
Milan 16
Orem 15
Chicago 12
London 12
Padova 12
Roxbury 12
Cotonou 11
Dublin 11
Johannesburg 11
Montreal 11
Turku 11
Warsaw 11
Changsha 10
Stockholm 10
Vientiane 10
Baghdad 9
Minsk 9
Atlanta 8
Baku 8
Hefei 8
The Dalles 8
Toronto 8
Ulan Bator 8
Andorra la Vella 7
Brooklyn 7
Denver 7
Des Moines 7
Frankfurt am Main 7
Kampala 7
Papeete 7
Podgorica 7
Reykjavik 7
Rome 7
Shenyang 7
Tallinn 7
Addis Ababa 6
Antananarivo 6
Brasília 6
Cairo 6
Conakry 6
Da Nang 6
Guayaquil 6
Harare 6
Hebei 6
Lahore 6
Madrid 6
Nairobi 6
Ouagadougou 6
Redondo Beach 6
Tianjin 6
Tokyo 6
Willemstad 6
Amman 5
Bamako 5
Banjul 5
Buenos Aires 5
Bắc Ninh 5
Castries 5
Chennai 5
Dar es Salaam 5
Jeddah 5
Karachi 5
Kigali 5
Kingston 5
Managua 5
Totale 3.719
Nome #
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 314
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 280
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 264
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 263
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 262
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 262
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 260
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 259
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 245
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 241
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 236
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 228
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 216
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 216
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 214
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 206
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 202
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 193
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 189
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 189
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 185
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 176
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 171
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 170
Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. 163
Which assay is the most suitable to investigate von Willebrand factor functional activity? 159
Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. 110
Antiphosphatidylserine/prothrombin antibodies define a high-risk antiphospholipid syndrome profile associated with organ damage 73
Totale 5.946
Categoria #
all - tutte 17.901
article - articoli 17.445
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022249 0 0 0 18 6 29 16 43 10 6 53 68
2022/2023297 56 38 7 30 57 31 2 18 37 3 18 0
2023/2024205 2 27 32 17 29 38 20 3 1 7 18 11
2024/2025664 1 50 42 36 91 26 30 33 53 24 116 162
2025/20262.893 134 212 355 437 232 110 487 234 350 159 114 69
2026/2027437 58 154 133 92 0 0 0 0 0 0 0 0
Totale 5.946